UCSD Human Research Protections Program


Beginning with the July 7, 2021 launch of the Kuali IRB system, use of the forms on these pages will be gradually phased out. The process will be complete by the end of July 2022. Please note the following:

For more information, see our May 22, 2021 News item .

The HRPP has both paper and electronic forms; in some cases, the data from the form can be submitted online directly to HRPP.

UC San Diego, HRPP forms' list

Biomed | SBS | RCHSD-only | Exempt Status | Approval-In-Principle | Non-UCSD "Centralized" IRBs | EBP/QA/QI | Stem Cells
Biomedical Research Forms
Studies typically conducted by UCSD faculty, staff, and students affiliated with the UCSD Health System or conducted at Rady Children's Hospital — San Diego
Social and Behavioral Sciences Research Forms
Studies typically conducted by UCSD faculty, staff, and students affiliated with the UCSD campus
RCHSD-only Research Forms
RCHSD researchers that have no affliation with UCSD and are requesting UCSD IRB oversight
Exempt Status Application Forms
Minimal risk studies that satisfy criteria for exemption from IRB review
NEW: For compliance reasons, the Approval-in-Principle application and process are no longer available. In the rare case that a funding agency has explicitly requested that the IRB document its awareness of a proposal that involves either indefinite plans or a delayed onset, please forward the following to irb@health.ucsd.edu:
  • The letter, email or award terms in which your funding agency explicitly requested IRB acknowledgment of a project that is not yet ready for IRB review.
  • The scientific design portion of the proposal (do not include budget or personnel information).
  • A brief summary of why you are not able to submit a protocol for IRB review at this time (e.g., animal work for Aims 1 and 2 needs to be completed before the human work for Aim 3 can be described for the IRB).
  • A projected date for when you will be able to submit a protocol for IRB review.
  • Your acknowledgment that you will not use award funds for human subjects research activity until you have obtained either IRB approval or certification of exemption from IRB review.
This e-mail process will be discontinued as of Kuali IRB Go-Live on July 7, 2021. You will be able to request this acknowledgment and provide the above documentation via a short application in Kuali irb2.
Non-UCSD "Centralized" IRBs Forms
UCSD has entered into agreements with non-UCSD IRBs including Western IRB, Copernicus Group IRB, Quorum Review IRB, and the NCI CIRB to provide "centralized" IRB oversight for specific types of clinical trials and other research involving human subjects
EBP/QA/QI Projects Forms
NEW FOR HEALTH SCIENCES EBP/QA/QI PROJECTS: Instead of submitting your proposal for IRB review or exemption, please submit to the UC San Diego Health Aligning and Coordinating QUality Improvement, Research, and Evaluation (ACQUIRE) Committee (AD login required). The ACQUIRE Committee is authorized to determine and document that a project is not regulated as "human subjects research." Please only apply to the IRB if your EBP/QA/QI project involves activities that are regulated as "human subjects research" or if the ACQUIRE Committee otherwise refers you for IRB review.

For Campus or Rady Children’s EBP/QA/QI projects, continue using the existing form(s) until July 7, 2021. Beginning July 7, you will use Kuali IRB for all new submissions. However, only the following EBP/QA/QI projects should be submitted:

  • Those with activities that are regulated as “human subjects research” and need an IRB review or exemption
  • When you need an administrative determination that a project is not regulated as “human subjects research.”
Rady Children’s is preparing to launch an internal review process similar to UC San Diego Health’s ACQUIRE Committee. More information is expected this fall. For questions regarding QI projects at RCHSD, contact Dr. Anthony Magit at amagit@health.ucsd.edu.

Stem Cells
For projects that require review by the SCRO Committee, complete the following form(s) and follow the instructions provided
Contact the Human Research Protections Program Office